Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Noxafil
Synonyms :
posaconazole
Class :
Antifungals, Systemic
Dosage forms & Strengths:Â
Oral suspensionÂ
40 mg/mlÂ
Injectable solutionÂ
18 mg/mlÂ
Delayed-release tabletÂ
100 mgÂ
Safety and efficacy are not seen in pediatrics below 13 years.Â
posaconazole has the potential to enhance the level or impact of intranasal dihydroergotamine intranasal by modulating the hepatic/intestinal enzyme CYP3A4 metabolism
when both drugs are combined, there may be an increase in the QTC interval  
rifabutin: they may diminish the serum concentration of posaconazole
It may enhance when combined with oxycodone by affecting CYP3A4 metabolism
QTc interval is increased both by lenvatinib and posaconazole
the effect of posaconazole is increased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
it increases the effect or level of palbociclib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
it increases the effect or level of ruxolitinib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
it increases the concentration of QT-prolonging CYP3A4 substrates in serum
may increase the level of effectiveness through P-glycoprotein MDR1 efflux transporter
it may enhance the risk of QTc prolongation when combined with amifampridine
has a synergistic effect over brentuximab vedotin by showing altered intestinal/hepatic CYP3A4 enzyme metabolism.
it increases the QT-c prolonging effect with gilteritinib
>10%:Â
Diarrhea Â
Pyrexia Â
Nausea Â
Hypokalemia Â
Rash Â
Headache Â
Vomiting Â
Epistaxis Â
Abdominal pain Â
Peripheral edemaÂ
Cough Â
Constipation Â
Hypomagnesemia Â
Decreased appetite Â
Hypertension Â
Thrombocytopenia Â
Upper abdominal painÂ
1-10%:Â
Anemia Â
Constipation Â
Asthenia Â
Chills Â
HypomagnesemiaÂ
Posaconazole is contraindicated in patients hypersensitive to the active ingredient.Â
Pregnancy consideration:Â Â
Insufficient data is available regarding any fetal defects caused due to drug intake during pregnancy.Â
Breastfeeding warnings:Â Â
No data is available regarding the excretion of the drug in breast milk.Â
Pregnancy category:Â
Patient information leafletÂ
Generic Name: posaconazoleÂ
Pronounced: po-sa-co-na-zoleÂ
Why do we use posaconazole?Â
Posaconazole is an antifungal agent. It is used to treat candida infections and oropharyngeal candidiasis.Â